{"id":"https://openalex.org/W4361908580","doi":"https://doi.org/10.1158/1078-0432.22451385.v1","title":"Supplementary Table 1 from Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer","display_name":"Supplementary Table 1 from Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908580","doi":"https://doi.org/10.1158/1078-0432.22451385.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22451385.v1","doi":"https://doi.org/10.1158/1078-0432.22451385.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22451385.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22451385.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062792047","display_name":"Steffan T. Nawrocki","orcid":"https://orcid.org/0000-0001-8767-3969","observed_orcids":["https://orcid.org/0000-0001-8767-3969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steffan T. Nawrocki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005922094","display_name":"Kevin R. Kelly","orcid":"https://orcid.org/0000-0002-3638-5956","observed_orcids":["https://orcid.org/0000-0002-3638-5956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin R. Kelly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091086352","display_name":"Peter G. Smith","orcid":"https://orcid.org/0000-0002-1931-7660","observed_orcids":["https://orcid.org/0000-0002-1931-7660"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter G. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036425742","display_name":"Claudia M. Espitia","orcid":"https://orcid.org/0000-0002-4109-2584","observed_orcids":["https://orcid.org/0000-0002-4109-2584"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudia M. Espitia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071632111","display_name":"Anthony P. Possemato","orcid":"https://orcid.org/0000-0001-7484-5549","observed_orcids":["https://orcid.org/0000-0001-7484-5549"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Possemato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032066425","display_name":"Sean A. Beausoleil","orcid":"https://orcid.org/0000-0002-3356-4641","observed_orcids":["https://orcid.org/0000-0002-3356-4641"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean A. Beausoleil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062887885","display_name":"Michael A. Milhollen","orcid":"https://orcid.org/0000-0003-1736-1219","observed_orcids":["https://orcid.org/0000-0003-1736-1219"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Milhollen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009761094","display_name":"Stephen J. Blakemore","orcid":"https://orcid.org/0009-0009-8524-3717","observed_orcids":["https://orcid.org/0009-0009-8524-3717"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Blakemore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101492076","display_name":"Michael Thomas","orcid":"https://orcid.org/0000-0001-9511-055X","observed_orcids":["https://orcid.org/0000-0001-9511-055X","https://orcid.org/0009-0008-0971-388X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Thomas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010026747","display_name":"Allison Berger","orcid":"https://orcid.org/0000-0003-1217-2005","observed_orcids":["https://orcid.org/0000-0003-1217-2005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison Berger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018391856","display_name":"Jennifer S. Carew","orcid":"https://orcid.org/0000-0002-8578-8292","observed_orcids":["https://orcid.org/0000-0002-8578-8292"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer S. Carew","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.6660000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.6660000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.1868000030517578,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.015399999916553497,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mln4924","display_name":"MLN4924","score":0.9419999718666077},{"id":"https://openalex.org/keywords/neddylation","display_name":"neddylation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.925000011920929},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":1.0},{"id":"https://openalex.org/keywords/proteomics","display_name":"proteomics","score":0.7279999852180481},{"id":"https://openalex.org/keywords/protein-expression-changes","display_name":"protein expression changes","score":0.5910000205039978},{"id":"https://openalex.org/keywords/e3-ubiquitin-ligase-inhibitors","display_name":"E3 ubiquitin ligase inhibitors","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C45005369","wikidata":"https://www.wikidata.org/wiki/Q21115705","display_name":"Neddylation","level":5,"score":0.9082530736923218},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5460784435272217},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.502190113067627},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4989433288574219},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.4976358711719513},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3782092332839966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3702414035797119},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.340747594833374},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3326687216758728},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3227081596851349},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3213668167591095},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2023274004459381},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.19500970840454102},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.19178402423858643},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1265510618686676},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10852888226509094},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.07043087482452393},{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22451385.v1","doi":"https://doi.org/10.1158/1078-0432.22451385.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22451385.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22451385","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Disrupting_Protein_NEDDylation_with_MLN4924_Is_a_Novel_Strategy_to_Target_Cisplatin_Resistance_in_Ovarian_Cancer/22451385","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22451385.v1","doi":"https://doi.org/10.1158/1078-0432.22451385.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22451385.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5299999713897705,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2222975708","https://openalex.org/W2021846401","https://openalex.org/W3048551493","https://openalex.org/W2792771883","https://openalex.org/W2083008763","https://openalex.org/W3171945197","https://openalex.org/W2974146152","https://openalex.org/W4389542606","https://openalex.org/W2053306150","https://openalex.org/W4385496679"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"71K,":[3],"Supplemental":[4],"Table":[5],"1.":[6],"Proteins":[7],"Altered":[8],">2-fold":[9],"by":[10],"Treatment":[11],"with":[12],"MLN4924.":[13]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}